Revenue: The sum of all revenue fields included for a company's operating activities.
Axsome Therapeutics, Inc. (AXSM) had Revenue of $118.77M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$118.77M |
$-74.91M |
|
$10.51M |
|
$108.25M |
|
$191.38M |
|
$-72.62M |
|
$-2.21M |
|
$-74.83M |
|
$-74.83M |
|
$-74.91M |
|
$-74.91M |
|
$-74.91M |
|
$-74.91M |
|
$-72.62M |
|
$-69.84M |
|
47.91M |
|
47.91M |
|
$-1.54 |
|
$-1.54 |
|
| Balance Sheet Financials | |
$485.06M |
|
$0.58M |
|
$83.43M |
|
$568.50M |
|
$230.10M |
|
$183.65M |
|
$281.38M |
|
$511.48M |
|
$57.02M |
|
$-1.92M |
|
$57.02M |
|
48.67M |
|
| Cash Flow Statement Financials | |
$-128.41M |
|
$-0.27M |
|
$57.84M |
|
$386.19M |
|
$315.35M |
|
$-70.84M |
|
$85.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
0.76 |
|
3.22 |
|
91.15% |
|
-61.14% |
|
-61.14% |
|
-- |
|
-63.00% |
|
-63.08% |
|
$-128.68M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.67 |
|
0.84 |
|
107.61 |
|
-131.39% |
|
3899.60% |
|
-13.18% |
|
-31.13% |
|
$1.17 |
|
$-2.69 |
|
$-2.68 |
|